Wikipedia
Previous article:
Novavax promises a turnaround & Lilly roils the obesity market
Next article: Argenx drug significantly slows progression of nerve disorder
Next article: Argenx drug significantly slows progression of nerve disorder
focus
hotspot
-
Readout Newsletter: Bristol, Sangamo, Gilead, and more
2025-10-02 10:46 -
Ebola: Gilead Sciences antiviral shows promise as new treatment
2025-10-02 10:24 -
Global childhood vaccinations edge closer to pre
2025-10-02 10:20 -
Eli Lilly to acquire Versanis in heated race for weight loss drugs
2025-10-02 10:15 -
First U.S. drug developed to treat liver disease MASH is approved
2025-10-02 10:04 -
RaDonda Vaught links Vanderbilt hospital issues to patient death
2025-10-02 09:00